This study evaluated the real-world use of a mobile app developed to support colorectal cancer (CRC) screening and post-polypectomy surveillance based on updated guidelines. Used over 12,000 times by healthcare professionals in Catalonia, the app helped optimize decision-making—particularly by reducing unnecessary colonoscopies. It recommended fecal occult blood testing (FOBT) for average-risk screening and deferred follow-up in 50% of surveillance cases. With a 72% retention rate, the app showed strong adoption and potential to enhance guideline adherence and resource use in CRC care.
Keep Reading
Add A Comment